Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer

  • Etude concernée: IFCT-0803
  • Auteurs / Authors: Trédaniel J, Barlési F, Le Péchoux C, Lerouge D, Pichon É, Le Moulec S, Moreau L, Friard S, Westeel V, Petit L, Carré O, Guichard F, Raffy O, Villa J, Prévost A, Langlais A, Morin F, Wislez M, Giraud P, Zalcman G, Mornex F
  • Journal / Conference: Cancer/Radiothérapie
  • Année / Year: 2022
  • PMID: 35260342
  • Lien vers la publication: https://pubmed.ncbi.nlm.nih.gov/35260342/
  • PDF: 1-s2.0-S127832182200035X-main.pdf